GlassScriptPhysician profile
Cassandra Weidman
NPI 1316309305
$5,391.84
in general payments reported to CMS, 2019-2025
28 companies · $3,870 in 2025
The $3,870 reported for 2025 was more than what 96% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $126 · 2020: $219 · 2021: $358 · 2022: $308 · 2023: $243 · 2024: $268 · 2025: $3,870.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $1,705 · Travel and Lodging: $1,575 · Food and Beverage: $1,101.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $1,705.19 |
| Travel and Lodging | $1,574.89 |
| Food and Beverage | $1,100.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $3,668.36 | 2023-2025 | Da Vinci Surgical System |
| Ethicon US, LLC | $316.46 | 2021-2025 | Vistaseal, Stratafix, Dermabond Prineo |
| Abbvie INC. | $295.42 | 2019-2023 | Orilissa |
| Therapeuticsmd, INC. | $169.11 | 2019-2022 | |
| Biogen, INC. | $111.28 | 2025 | Zurzuvae |
| Daiichi Sankyo INC. | $111.18 | 2021-2024 | Injectafer |
| Evofem Biosciences, INC. | $99.94 | 2021-2022 | |
| Boston Scientific Corporation | $74.82 | 2020-2025 | Solyx Sis System, Axonics |
| Hologic Sales and Service, LLC | $71.58 | 2021-2025 | Myosure Tissue Removal Device |
| Medical Device Business Services, INC. | $52.20 | 2021 | |
| Mayne Pharma Commercial LLC | $50.74 | 2022-2025 | |
| Applied Medical Resources Corporation | $41.46 | 2024 | |
| Becton, Dickinson and Company | $37.85 | 2020-2022 | |
| Organon LLC | $36.70 | 2022-2025 | Nexplanon |
| Coloplast Corp | $26.41 | 2023 | Altis |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avanos Medical | $23.49 | 2024 | On-Q* Pump and Accessories |
| Eyepoint US, INC. | $22.93 | 2020 | |
| Sumitomo Pharma America, INC. | $20.11 | 2023 | Myfembree |
| Bayer Healthcare Pharmaceuticals INC. | $19.90 | 2022 | |
| Genmab U.S., INC. | $19.85 | 2023 | Tivdak |
| Exeltis, USA INC. | $19.67 | 2021 | |
| Roche Diagnostics Corporation | $19.21 | 2021 | |
| Solventum Corporation | $15.54 | 2025 | Prevena |
| C. R. Bard, INC. & Subsidiaries | $14.74 | 2024 | Bd Onclarity |
| Octapharma USA, INC. | $13.83 | 2025 | Fibryga |
| Medtronic, INC. | $13.48 | 2025 | Truclear |
| Biohaven Pharmaceuticals, INC. | $13.20 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $12.38 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cassandra Weidman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.